Pharmacogenetics of efavirenz: adherence and virologic outcomes.
David J
DJ
Cennimo
D000480:Alkynes; D019380:Anti-HIV Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D048588:Benzoxazines / Q000493:pharmacokinetics*; D044383:Black People / Q000235:genetics*; D003521:Cyclopropanes; D015658:HIV Infections / Q000188:drug therapy / Q000208:ethnology*; D015497:HIV-1; D006801:Humans; D010349:Patient Compliance; D010597:Pharmacogenetics; D018894:Reverse Transcriptase Inhibitors / Q000493:pharmacokinetics* / Q000627:therapeutic use
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz